Pharma/Fine Chemicals Roundup – July 31

LONZA REPORTS FALL IN FIRST-HALF PROFITS Lonza recorded a 3.1% fall in first-half profits compared with the year-ago period, to SF94 million ($94.5 million). First-half sales increased, however, by 64.6%, to SF1.96 billion, mainly due to the acquisition of biocides maker Arch Chemicals (Norwalk, CT), which was completed last October, for $1.4 billion, Lonza says. EBIT for the first half increased by 23.5%, to SF168 million. U.S. FDA LIFTS IMPORT ALERT ON DR. REDDY’S API FACILITY IN MEXICO Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers